Planning

Managed Service Contract for Viral Molecular Pathology Testing

UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST

This public procurement record has 1 release in its history.

Planning

16 Oct 2017 at 11:02

Summary of the contracting process

The University Hospitals Birmingham NHS Foundation Trust is initiating a procurement process for a Managed Service Contract for Viral Molecular Pathology Testing, valued at £300,000. This project falls under the category of laboratory, optical, and precision equipment and will be based in Birmingham, West Midlands, England. The procurement is currently in the planning stage, with a future notice date set for 6 November 2017. The contract period is scheduled to commence on 8 January 2018 and conclude on 7 January 2021.

This tender presents substantial opportunities for businesses in the medical and laboratory equipment sectors, particularly those specialising in molecular pathology services and cancer testing solutions. Companies offering comprehensive managed services, equipment, and reagents for genetic testing, especially for EGFR, BRAF, KRAS, and NRAS mutations, would be particularly well-positioned to compete. The expected provision of innovative testing solutions could lead to ongoing business growth within the healthcare sector.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Managed Service Contract for Viral Molecular Pathology Testing

Notice Description

The Molecular Pathology Diagnostic Service (MPDS) is looking to advertise provision of a managed service (MSC) encompassing EGFR, BRAF, KRAS and NRAS testing over a range of cancer types. The trust will be looking at solutions to provide equipment and reagents for the molecular testing of clinically relevant mutations in EGFR, BRAF, KRAS and NRAS from DNA extracted from formalin fixed paraffin embedded tissue and circulating tumour DNA from plasma. There is an expectation that the FFPE DNA used in the tests above may be required in subsequent tests not covered by this managed service therefore provision for DNA extraction from FFPE material is not included within the scope of this MSC and supplied solutions for the assays required must be agnostic of DNA extraction methods used. Extraction and testing of circulating tumour DNA from plasma for use in EGFR mutation testing will be included in the scope of the MSC.

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-78aea189-7382-4e24-9a29-83726029a0e8
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/2692f10f-e2db-425d-b6b7-358b3c1b03de
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Planned Procurement Notice
Procurement Type
Standard
Procurement Category
Not specified
Procurement Method
Not Specified
Procurement Method Details
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

38 - Laboratory, optical and precision equipments (excl. glasses)


CPV Codes

38000000 - Laboratory, optical and precision equipments (excl. glasses)

Notice Value(s)

Tender Value
£300,000 £100K-£500K
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
16 Oct 20178 years ago
Submission Deadline
Not specified
Future Notice Date
6 Nov 2017Expired
Award Date
Not specified
Contract Period
8 Jan 2018 - 7 Jan 2021 3-4 years
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BIRMINGHAM
Postcode
B15 2WB
Post Town
Birmingham
Country
England

Major Region (ITL 1)
TLG West Midlands (England)
Basic Region (ITL 2)
TLG3 West Midlands
Small Region (ITL 3)
TLG31 Birmingham
Delivery Location
TLG West Midlands (England)

Local Authority
Birmingham
Electoral Ward
Edgbaston
Westminster Constituency
Birmingham Edgbaston

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-78aea189-7382-4e24-9a29-83726029a0e8-2017-10-16T12:02:22+01:00",
    "date": "2017-10-16T12:02:22+01:00",
    "ocid": "ocds-b5fd17-78aea189-7382-4e24-9a29-83726029a0e8",
    "language": "en",
    "initiationType": "tender",
    "planning": {
        "documents": [
            {
                "id": "1",
                "documentType": "plannedProcurementNotice",
                "description": "Future opportunity notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/2692f10f-e2db-425d-b6b7-358b3c1b03de",
                "datePublished": "2017-10-16T12:02:22+01:00",
                "format": "text/html",
                "language": "en"
            },
            {
                "id": "2",
                "documentType": "tenderNotice",
                "description": "Link to e-procurement portal (Bravo Solutions)",
                "url": "https://nhs.bravosolution.co.uk/nhs_collaborative/web/login.html"
            }
        ]
    },
    "tender": {
        "id": "tender_155786/625352",
        "title": "Managed Service Contract for Viral Molecular Pathology Testing",
        "description": "The Molecular Pathology Diagnostic Service (MPDS) is looking to advertise provision of a managed service (MSC) encompassing EGFR, BRAF, KRAS and NRAS testing over a range of cancer types. The trust will be looking at solutions to provide equipment and reagents for the molecular testing of clinically relevant mutations in EGFR, BRAF, KRAS and NRAS from DNA extracted from formalin fixed paraffin embedded tissue and circulating tumour DNA from plasma. There is an expectation that the FFPE DNA used in the tests above may be required in subsequent tests not covered by this managed service therefore provision for DNA extraction from FFPE material is not included within the scope of this MSC and supplied solutions for the assays required must be agnostic of DNA extraction methods used. Extraction and testing of circulating tumour DNA from plasma for use in EGFR mutation testing will be included in the scope of the MSC.",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "38000000",
            "description": "Laboratory, optical and precision equipments (excl. glasses)"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "postalCode": "B15 2WB"
                    },
                    {
                        "region": "West Midlands",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 300000,
            "currency": "GBP"
        },
        "communication": {
            "futureNoticeDate": "2017-11-06T00:00:00Z"
        },
        "contractPeriod": {
            "startDate": "2018-01-08T00:00:00Z",
            "endDate": "2021-01-07T23:59:59Z"
        },
        "suitability": {
            "sme": false,
            "vcse": false
        }
    },
    "parties": [
        {
            "id": "GB-CFS-44226",
            "name": "University Hospitals Birmingham NHS Foundation Trust",
            "identifier": {
                "legalName": "University Hospitals Birmingham NHS Foundation Trust"
            },
            "address": {
                "streetAddress": "Mindelsohn Way",
                "locality": "Birmingham",
                "postalCode": "B15 2WB",
                "countryName": "England"
            },
            "contactPoint": {
                "email": "Kirsty.Walker@uhb.nhs.uk",
                "telephone": "+44 1216978332"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-44226",
        "name": "University Hospitals Birmingham NHS Foundation Trust"
    }
}